Am J Transplant, Volume 19, Suppl 3 Archives - Page 86 of 214 - ATC Abstracts

2019 American Transplant Congress
Investigating Deceased Donor Kidney Discard Trend – An Opportunity To Expand The Donor Pool
J. A. Shah¹, D. P. Borle¹, K. Koontz², W. Irish¹, K. V. Ravindra¹
¹Abdominal Transplant Surgery, Duke University Medical Center, Durham, NC, ²Carolina Donor Services, Durham, NC
*Purpose: As the number of patients awaiting kidney transplantation increases from year to year, centers must maximize efforts to transplant kidneys procured. One way of…
2019 American Transplant Congress
DR53, You Can’t See Me: A Deceased Donor Tale of Ambiguous Typing
S. Dionne¹, S. Shetty¹, L. Santiago¹, K. Klama²
¹VRL Eurofins, Centennial, CO, ²VRL Eurofins, Philadelphia, PA
*Purpose: Our laboratory performs STAT HLA typing for an OPO using RT-PCR methodology. A 46 year old, male Caucasian deceased donor was worked up by…
2019 American Transplant Congress
Time within Therapeutic Range: A Comparison of Three Tacrolimus Formulations within Ninety Days of Renal Transplant
S. Patel, K. Khalil, A. Lichvar, E. Benedetti, P. West-Thielke
University of Illinois Hospital and Health Sciences System, Chicago, IL
*Purpose: Optimizing tacrolimus (TAC) time within therapeutic range (TTR) has been shown to improve outcomes post-transplant. To date, there are no studies assessing differences in…
2019 American Transplant Congress
Belatacept Use in High Kidney Donor Profile Index Kidney Transplant Recipients
D. Britt¹, A. Gharabagi¹, K. Botkin¹, T. Horwedel², C. Carthon¹, J. Hagopian¹
¹Pharmacy, Barnes-Jewish Hospital, St. Louis, MO, ²Veloxis Pharmaceuticals, Cary, NC
*Purpose: To determine whether the use of belatacept is associated with renal function preservation in kidney transplant recipients from donors with a kidney donor profile…
2019 American Transplant Congress
Impact of HLA-DR Matching on HLA-DQ Matching Status and the Development of Anti-HLA-DQ De Novo DSA under Calcineurin Inhibitor or Belatacept Immunosuppression
V. Jucaud¹, H. Gebel², R. Bray², M. Polinsky³, M. Everly¹
¹Terasaki Research Institute, Los Angeles, CA, ²Emory University, Atlanta, GA, ³Bristol-Myers Squibb, Princeton, NJ
*Purpose: De novo donor-specific HLA antibodies (dnDSA) that develop after kidney transplantation target more frequently allo-HLA-DQ antigens in comparison to other allo-HLA antigens. Yet, organ…
2019 American Transplant Congress
Combined Liver and Delayed Kidney Transplantation (CLKT) Enables Similar Patient Survival as Liver Transplantation Alone (LTA): Propensity Score-Based Comparison
B. Ekser¹, C. A. Kubal¹, R. S. Mangus¹, P. Mihaylov¹, J. A. Fridell¹, L. R. Timsina¹, M. Lacerda², M. Ghabril², J. A. Powelson¹, W. C. Goggins¹
¹Transplant Division - Department of Surgery - Indiana University, Indianapolis, IN, ²Gastroenterology, Indiana University, Indianapolis, IN
*Purpose: We previously showed the positive impact of delayed KT in CLKT on patient survival compared to simultaneous KT. It is well known from the…
2019 American Transplant Congress
Recipient Sex Interacts with Primary Diagnosis to Affect Liver Transplant Graft Survival
D. Yoeli¹, R. Choudhury¹, H. Moore¹, M. Simpson², A. Sauaia¹, E. Pomfret¹, T. Nydam¹
¹Surgery, University of Colorado, Denver, CO, ²Surgery, Lahey Clinic, Burlington, MA
*Purpose: While recipient sex is a commonly studied risk factor in liver transplantation, findings have been contradictory. We hypothesized that different causes of liver disease…
2019 American Transplant Congress
Orthotopic Liver Transplantation in MPV17 Deficiency: A Case Series
E. A. Gerzina¹, E. D. Witte¹, M. L. Kueht², R. W. Himes³
¹Baylor College of Medicine, Houston, TX, ²Department of Surgery, Division of Abdominal Transplant, Baylor College of Medicine, Houston, TX, ³Pediatrics--Gastroenterology, Baylor College of Medicine, Houston, TX
*Purpose: The purpose of this study was to consider the clinical courses of two patients with MPV17 mutations and to evaluate the efficacy of liver…
2019 American Transplant Congress
Targeted Antifungal Prophylaxis in Liver Transplant Recipients: Two Year, Retrospective Cohort Analysis
N. Persun¹, J. Doyon², E. Blumberg², S. Prenner², V. Khungar², P. Abt³, C. Sammons¹
¹Pharmacy, Hospital of the University of Pennsylvania, Philadelphia, PA, ²Medicine, Hospital of the University of Pennsylvania, Philadelphia, PA, ³Surgery, Hospital of the University of Pennsylvania, Philadelphia, PA
*Purpose: No consensus exists regarding systemic antifungal prophylaxis in liver transplant recipients (LTRs) in terms of optimal duration, choice of agent, or risk factors to…
2019 American Transplant Congress
Infectious Complications in Kidney Transplant Recipients Age 65 and Older
L. E. Liriano-Ward¹, M. Barbachan e Silva², Y. Azzi¹, M. Ajaimy¹, A. Cambell¹, J. Graham¹, J. Rocca¹, C. Pynadath¹, G. Nair¹, O. Andacoglu¹, S. Greenstein¹, P. Ó Broin², E. Akalin¹
¹Transplant, Einstein/Montefiore Medical Center, Bronx, NY, ²School of Mathematics, Statistics & Applied Mathematics, National University of Ireland Galway, Galway, Ireland
*Purpose: Kidney transplant recipients age 65 years and older are at higher risk for development of infections. We aimed to investigate the incidence of both…